Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 58Prostatic Neoplasms, Castration-Resistant 4Metastatic Castration-resistant Prostate Cancer 4Prostate Cancer Metastatic 2Neoplasm Metastasis 2Metastatic Castration-Resistant Prostate Cancer 2Urogenital Neoplasms 1Urinary Bladder Neoplasms 1Stage II Prostate Adenocarcinoma 1Sleep Initiation and Maintenance Disorders 1Prostatic Diseases 1Prostate Adenocarcinoma 1Ovarian Neoplasms 1Oligometastatic Prostate Carcinoma 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms by Site 1Neoplasms 1NSCLC Harboring NRG1 Fusion 1Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1Metastatic Hormone Refractory Prostate Cancer 1Metastatic Castration-sensitive Prostate Cancer 1Metastatic Castration-resistant Prostate Neoplasms 1Metastatic Castration Resistant Prostate Cancer 1Male Urogenital Diseases 1Genital Neoplasms, Male 1Fatigue 1Depression 1Dementia 1Cognitive Dysfunction 1Carcinoma, Transitional Cell 1

Interventions

mazdutide 1enzalutamide 1XENP 1595 1UE2343 1Standard of Care 1Referral and Consultation 1Prednisone 1Hormones 1Gonadotropin-Releasing Hormone 1Exercise 1Electroencephalography 1Drug Delivery Systems 1Decision Support Techniques 1Accidental Falls 1Abiraterone Acetate 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dementia × Abiraterone Acetate × 1 year × Clear all
NCT03016741 2026-02-24

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

Northwestern University

Phase 4 Active not recruiting
100 enrolled
Genitourinary

Dementia, Prostatic Neoplasms, Cognitive Dysfunction, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡